Annual Short Term Debt
$2.95 B
-$635.98 M-17.75%
December 1, 2024
Summary
- As of February 7, 2025, GSK annual short term debt is $2.95 billion, with the most recent change of -$635.98 million (-17.75%) on December 1, 2024.
- During the last 3 years, GSK annual short term debt has fallen by -$1.91 billion (-39.35%).
- GSK annual short term debt is now -67.51% below its all-time high of $9.07 billion, reached on December 31, 2019.
Performance
GSK Short Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Short Term Debt
$3.77 B
-$490.26 M-11.52%
September 30, 2024
Summary
- As of February 7, 2025, GSK quarterly short term debt is $3.77 billion, with the most recent change of -$490.26 million (-11.52%) on September 30, 2024.
- Over the past year, GSK quarterly short term debt has dropped by -$2.14 billion (-36.25%).
- GSK quarterly short term debt is now -70.71% below its all-time high of $12.86 billion, reached on June 30, 2019.
Performance
GSK Quarterly Short Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Short Term Debt Formula
Short-Term Debt = Current Portion of Long-Term Debt + Short-Term Loans + Commercial Paper + Other Short-Term Borrowings
GSK Short Term Debt Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -17.8% | -36.3% |
| 3 y3 years | -39.4% | -30.1% |
| 5 y5 years | -67.5% | -30.1% |
GSK Short Term Debt Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -39.4% | at low | -49.6% | +20.8% |
| 5 y | 5-year | -67.5% | at low | -58.5% | +20.8% |
| alltime | all time | -67.5% | +1716.8% | -70.7% | +2222.0% |
GSK Short Term Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $2.95 B(-17.7%) | - |
| Sep 2024 | - | $3.77 B(-11.5%) |
| Jun 2024 | - | $4.26 B(+28.9%) |
| Mar 2024 | - | $3.30 B(-7.8%) |
| Dec 2023 | $3.58 B(-25.1%) | $3.58 B(-39.4%) |
| Sep 2023 | - | $5.91 B(-20.9%) |
| Jun 2023 | - | $7.47 B(+41.5%) |
| Mar 2023 | - | $5.28 B(+10.3%) |
| Dec 2022 | $4.78 B(-1.6%) | $4.78 B(+53.3%) |
| Sep 2022 | - | $3.12 B(-22.7%) |
| Jun 2022 | - | $4.04 B(-25.1%) |
| Mar 2022 | - | $5.39 B(+10.9%) |
| Dec 2021 | $4.86 B(-4.3%) | $4.86 B(-25.7%) |
| Sep 2021 | - | $6.54 B(-6.3%) |
| Jun 2021 | - | $6.98 B(+60.0%) |
| Mar 2021 | - | $4.36 B(-14.1%) |
| Dec 2020 | $5.08 B(-44.0%) | $5.08 B(-19.7%) |
| Sep 2020 | - | $6.32 B(-13.9%) |
| Jun 2020 | - | $7.34 B(-18.3%) |
| Mar 2020 | - | $8.99 B(-0.9%) |
| Dec 2019 | $9.07 B(+23.4%) | $9.07 B(-10.2%) |
| Sep 2019 | - | $10.10 B(-21.5%) |
| Jun 2019 | - | $12.86 B(+17.2%) |
| Mar 2019 | - | $10.97 B(+49.3%) |
| Dec 2018 | $7.35 B(+92.5%) | $7.35 B(+94.4%) |
| Sep 2018 | - | $3.78 B(-16.7%) |
| Jun 2018 | - | $4.54 B(-6.0%) |
| Mar 2018 | - | $4.82 B(+26.4%) |
| Dec 2017 | $3.82 B(-24.7%) | $3.82 B(-40.0%) |
| Sep 2017 | - | $6.37 B(-26.0%) |
| Jun 2017 | - | $8.60 B(+84.3%) |
| Mar 2017 | - | $4.67 B(-8.0%) |
| Dec 2016 | $5.07 B(+161.8%) | $5.07 B(-1.2%) |
| Sep 2016 | - | $5.13 B(-15.0%) |
| Jun 2016 | - | $6.04 B(+240.7%) |
| Mar 2016 | - | $1.77 B(-8.6%) |
| Dec 2015 | $1.94 B(-57.7%) | $1.94 B(-10.1%) |
| Sep 2015 | - | $2.15 B(-44.6%) |
| Jun 2015 | - | $3.89 B(-19.0%) |
| Mar 2015 | - | $4.80 B(+4.7%) |
| Dec 2014 | $4.58 B(-0.4%) | $4.58 B(-47.2%) |
| Sep 2014 | - | $8.67 B(+62.0%) |
| Jun 2014 | - | $5.35 B(+73.2%) |
| Mar 2014 | - | $3.09 B(-32.8%) |
| Dec 2013 | $4.60 B(-21.6%) | $4.60 B(+3.4%) |
| Sep 2013 | - | $4.45 B(+25.0%) |
| Jun 2013 | - | $3.56 B(+15.8%) |
| Mar 2013 | - | $3.07 B(-47.6%) |
| Dec 2012 | $5.87 B(+41.1%) | $5.87 B(-13.0%) |
| Sep 2012 | - | $6.74 B(+18.8%) |
| Jun 2012 | - | $5.67 B(+30.6%) |
| Mar 2012 | - | $4.34 B(+4.5%) |
| Dec 2011 | $4.16 B(+825.6%) | $4.16 B(+205.7%) |
| Sep 2011 | - | $1.36 B(-18.6%) |
| Jun 2011 | - | $1.67 B(+302.8%) |
| Mar 2011 | - | $414.61 M(-7.7%) |
| Dec 2010 | $449.13 M | $449.13 M(-26.3%) |
| Sep 2010 | - | $609.61 M(-9.9%) |
| Jun 2010 | - | $676.87 M(-56.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2010 | - | $1.57 B(-34.0%) |
| Dec 2009 | $2.38 B(+69.9%) | $2.38 B(-21.2%) |
| Sep 2009 | - | $3.02 B(+54.7%) |
| Jun 2009 | - | $1.95 B(+6.6%) |
| Mar 2009 | - | $1.83 B(+30.7%) |
| Dec 2008 | $1.40 B(-79.9%) | $1.40 B(-43.3%) |
| Sep 2008 | - | $2.47 B(+7.2%) |
| Jun 2008 | - | $2.31 B(-35.4%) |
| Mar 2008 | - | $3.57 B(-48.8%) |
| Dec 2007 | $6.97 B(+395.7%) | $6.97 B(+70.9%) |
| Sep 2007 | - | $4.08 B(+72.8%) |
| Jun 2007 | - | $2.36 B(-0.5%) |
| Mar 2007 | - | $2.37 B(+68.7%) |
| Dec 2006 | $1.41 B(-61.0%) | $1.41 B(+15.0%) |
| Sep 2006 | - | $1.22 B(+19.0%) |
| Jun 2006 | - | $1.03 B(-31.5%) |
| Mar 2006 | - | $1.50 B(-58.4%) |
| Dec 2005 | $3.60 B(+18.7%) | $3.60 B(+26.3%) |
| Sep 2005 | - | $2.85 B(-6.8%) |
| Jun 2005 | - | $3.06 B(-4.0%) |
| Mar 2005 | - | $3.18 B(+4.9%) |
| Dec 2004 | $3.03 B(+17.1%) | $3.03 B(+44.7%) |
| Sep 2004 | - | $2.10 B(+5.1%) |
| Jun 2004 | - | $1.99 B(-22.4%) |
| Mar 2004 | - | $2.57 B(-0.9%) |
| Dec 2003 | $2.59 B(+3.7%) | $2.59 B(-2.3%) |
| Sep 2003 | - | $2.65 B(+17.3%) |
| Jun 2003 | - | $2.26 B(+8.1%) |
| Mar 2003 | - | $2.09 B(-16.3%) |
| Dec 2002 | $2.50 B(-18.9%) | $2.50 B(-8.8%) |
| Sep 2002 | - | $2.74 B(-29.2%) |
| Jun 2002 | - | $3.88 B(+32.8%) |
| Mar 2002 | - | $2.92 B(-5.3%) |
| Dec 2001 | $3.08 B(-9.3%) | $3.08 B(+11.0%) |
| Sep 2001 | - | $2.78 B(-0.4%) |
| Jun 2001 | - | $2.79 B(-16.9%) |
| Mar 2001 | - | $3.36 B(-1.3%) |
| Dec 2000 | $3.40 B(-6.5%) | $3.40 B(-24.1%) |
| Sep 2000 | - | $4.48 B(-4.4%) |
| Jun 2000 | - | $4.69 B(-2.7%) |
| Mar 2000 | - | $4.82 B(+32.5%) |
| Dec 1999 | $3.64 B(+66.9%) | $3.64 B(+17.7%) |
| Jun 1999 | - | $3.09 B(+41.9%) |
| Dec 1998 | $2.18 B(+11.4%) | $2.18 B(+4.0%) |
| Jun 1998 | - | $2.10 B(+7.1%) |
| Dec 1997 | $1.96 B(-25.6%) | $1.96 B(-25.6%) |
| Dec 1996 | $2.63 B(-43.6%) | $2.63 B(+79.2%) |
| Dec 1995 | $4.66 B(+217.8%) | - |
| Jun 1995 | - | $1.47 B(+137.9%) |
| Jun 1995 | $1.47 B(+137.9%) | - |
| Jun 1994 | $616.20 M(-31.6%) | $616.20 M(-31.6%) |
| Jun 1993 | $900.69 M(+29.5%) | $900.69 M(+29.5%) |
| Jun 1992 | $695.40 M(-50.8%) | $695.40 M(-50.8%) |
| Jun 1991 | $1.41 B(+90.7%) | $1.41 B(+90.7%) |
| Jun 1990 | $740.77 M(+236.6%) | $740.77 M(+236.6%) |
| Jun 1989 | $220.07 M(-48.9%) | $220.07 M(-48.9%) |
| Jun 1988 | $430.63 M(+35.8%) | $430.63 M(+35.8%) |
| Jun 1987 | $317.15 M(+95.5%) | $317.15 M(+95.5%) |
| Jun 1986 | $162.24 M | $162.24 M |
FAQ
- What is GSK annual short term debt?
- What is the all time high annual short term debt for GSK?
- What is GSK annual short term debt year-on-year change?
- What is GSK quarterly short term debt?
- What is the all time high quarterly short term debt for GSK?
- What is GSK quarterly short term debt year-on-year change?
What is GSK annual short term debt?
The current annual short term debt of GSK is $2.95 B
What is the all time high annual short term debt for GSK?
GSK all-time high annual short term debt is $9.07 B
What is GSK annual short term debt year-on-year change?
Over the past year, GSK annual short term debt has changed by -$635.98 M (-17.75%)
What is GSK quarterly short term debt?
The current quarterly short term debt of GSK is $3.77 B
What is the all time high quarterly short term debt for GSK?
GSK all-time high quarterly short term debt is $12.86 B
What is GSK quarterly short term debt year-on-year change?
Over the past year, GSK quarterly short term debt has changed by -$2.14 B (-36.25%)